USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL

被引:0
|
作者
Danese, Silvio
Vermeire, Severine
D'Haens, Geert
Panes, Julian
Dignass, Axel
Magro, Fernando
Nazar, Maciej
Le Bars, Manuela
Lahaye, Marjolein
Ni, Lioudmila
Gaya, Daniel R.
Peyrin-Biroulet, Laurent
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa073
引用
收藏
页码:S409 / S409
页数:1
相关论文
共 50 条
  • [31] Spheramine improves health-related quality of life in patients with moderate to advanced Parkinson's disease
    Stover, N. P.
    Watts, R. L.
    Freeman, A.
    Delong, M.
    Roy, B. A. E.
    Elke, R.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S131 - S131
  • [32] Omalizumab Improves Asthma Symptoms, Asthma Control, and Health-Related Quality of Life in Chinese Patients With Moderate-to-Severe Asthma
    Li, Jing
    Kang, Jian
    Wang, Changzheng
    Yang, Jing
    Humphries, Michael
    Greenberg, Steven
    Zhong, Nanshan
    [J]. CHEST, 2016, 149 (04) : 6A - 6A
  • [33] The impact of ixekizumab treatment on health-related quality of life in patients with moderate-to-severe psoriasis: results from UNCOVER-1
    Augustin, M.
    Gordon, K.
    Nikai, E.
    Edson-Heredia, E.
    Zhu, B.
    Goldblum, O. M.
    Carlier, H.
    Langley, R. G.
    [J]. EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E9 - E9
  • [34] Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial
    Nakagawa, Hidemi
    Schenkel, Brad
    Kato, Mai
    Kato, Takeshi
    Igarashi, Atsuyuki
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (09): : 761 - 769
  • [35] Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study
    Dauden, E.
    Pujol, R. M.
    Sanchez-Carazo, J. L.
    Toribio, J.
    Vanaclocha, F.
    Puig, L.
    Yebenes, M.
    Sabater, E.
    Casado, M. A.
    Caloto, M. T.
    Aragon, B.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2013, 104 (09): : 807 - 814
  • [36] Health-related quality of life in children with moderate-to-severe traumatic brain injury
    Erickson, Sarah J.
    Montague, Erica Q.
    Gerstle, Melissa A.
    [J]. DEVELOPMENTAL NEUROREHABILITATION, 2010, 13 (03) : 175 - 181
  • [37] Enteral Nutrition Improves Health-Related Quality Of Life in Crohn's Disease Patients with Long Disease Duration
    Kuriyama, Motoaki
    Kato, Jun
    Morimoto, Naofumi
    Fujimoto, Tsuyoshi
    Kono, Hiroyuki
    Okano, Nobuaki
    Miyaike, Jiro
    Morita, Takechiyo
    Okada, Hiroyuki
    Suzuki, Seiyuu
    Yoshioka, Toshifumi
    Shiode, Junji
    Shiratori, Yasushi
    Yamamoto, Kazuhide
    [J]. HEPATO-GASTROENTEROLOGY, 2009, 56 (90) : 321 - 327
  • [38] Risankizumab Versus Ustekinumab for the Achievement of Endoscopic Outcomes in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 3b SEQUENCE Trial
    Peyrin-Biroulet, L.
    Bossuyt, P.
    Regueiro, M.
    Schreiber, S.
    Gecse, K.
    Irving, P.
    D'Haens, G.
    Cao, Q.
    Neimark, E.
    Huang, X.
    Anschutz, T.
    Kligys, K.
    O'Brien, D.
    Panaccione, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I90 - I91
  • [39] Molecular response to ustekinumab in moderate-to-severe Crohn's disease by serum protein and biopsy gene expression analysis: results from Ustekinumab phase 3 studies
    Li, K.
    Hayden, K.
    Wadman, E.
    Bhagat, S.
    Emrich, S.
    Jacobstein, D.
    Gasink, C.
    Brodmerkel, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S57 - S58
  • [40] MOLECULAR RESPONSE TO USTEKINUMAB IN MODERATE-TO-SEVERE CROHN'S DISEASE BY SERUM PROTEIN AND BIOPSY GENE EXPRESSION ANALYSIS: RESULTS FROM USTEKINUMAB PHASE 3 STUDIES
    Li, Katherine
    Hayden, Karen
    Wadman, Eric
    Bhagat, Sunita
    Emrich, Scott
    Jacobstein, Douglas
    Gasink, Christopher
    Brodmerkel, Carrie
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S986 - S986